Average Co-Inventor Count = 9.49
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (7 from 3,923 patents)
2. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
3. University of Pennsylvania (2,595 patents)
9 patents:
1. 12209144 - Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
2. 11999802 - Compositions and methods for selective protein degradation
3. 11813306 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
4. 11026993 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
5. 9982017 - Synthetic apelin mimetics for the treatment of heart failure
6. 9067971 - Synthetic apelin mimetics for the treatment of heart failure
7. 8877900 - AX132 PCSK9 antagonists
8. 8802827 - AX1 PCSK9 antagonists
9. 8673848 - Synthetic apelin mimetics for the treatment of heart failure